Laboratory of Behavioral Neuroscience, Ningbo Addiction Research and Treatment Center, Key Laboratory of Addiction Research of Zhejiang Province, School of Medicine, Ningbo Institute of Microcirculation and Henbane, Ningbo University, Ningbo, China.
Department of Medical Services, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
J Clin Lab Anal. 2020 Nov;34(11):e23486. doi: 10.1002/jcla.23486. Epub 2020 Aug 3.
Drug addiction is an uncontrolled, chronic, and recurrent encephalopathy that presently lacks specific and characteristic biomarkers for diagnosis and treatment. As regulators of gene expression, microRNAs (miRNAs) are increasingly used for diagnostic and prognostic purposes in various disease states. Previous studies indicated that miRNAs play important roles in the development and progression of drug addictions, including addiction to methamphetamine, cocaine, alcohol, and heroin.
We identified significant miRNAs using the microarray method and then validated the hsa-miR-181a expression levels in 53 heroin addiction patients and 49 normal controls using quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). Finally, the potential associations between transcriptional levels in heroin addiction patients and their clinicopathological features were analyzed.
A total of 2006 miRNAs were differentially expressed between heroin addiction patients and normal controls. The top 10 up-regulated miRNAs in patients were hsa-miR-21a, hsa-miR-181a, hsa-miR-4459, hsa-miR-4430, hsa-miR-4306, hsa-miR-22-3P, hsa-miR-486-5P, hsa-miR-371b-5P, hsa-miR-92a-3P, and hsa-miR-5001-5P. The top 10 down-regulated miRNAs in patients were hsa-miR-3195, hsa-miR-4767, hsa-miR-3135b, hsa-miR-6087, hsa-miR-1181, hsa-miR-4785, hsa-miR-718, hsa-miR-3141, hsa-miR-652-5P, and hsa-miR-6126. The expression level of hsa-miR-181a in heroin addiction patients was significantly increased compared with that in normal controls (P < .001). The area under the receiver operating characteristic curve of hsa-miR-181a was 0.783, the sensitivity was 0.867, and the specificity was 0.551.
The increased expression of hsa-miR-181a in the plasma of heroin patients may be a consequence of the pathological process of heroin abuse. This study highlights the potential of hsa-miR-181a as a novel biomarker for the diagnosis of heroin addiction.
药物成瘾是一种不受控制的、慢性的、复发性脑病,目前缺乏用于诊断和治疗的特异性和特征性生物标志物。作为基因表达的调节剂,microRNAs(miRNAs)越来越多地用于各种疾病状态的诊断和预后目的。先前的研究表明,miRNAs 在药物成瘾的发展和进展中发挥重要作用,包括对甲基苯丙胺、可卡因、酒精和海洛因的成瘾。
我们使用微阵列方法鉴定了显著的 miRNAs,然后使用定量实时逆转录聚合酶链反应(qRT-PCR)在 53 名海洛因成瘾患者和 49 名正常对照中验证了 hsa-miR-181a 的表达水平。最后,分析了海洛因成瘾患者转录水平与其临床病理特征之间的潜在关联。
海洛因成瘾患者和正常对照组之间共有 2006 个 miRNAs 表达差异。患者中上调最多的前 10 个 miRNAs 是 hsa-miR-21a、hsa-miR-181a、hsa-miR-4459、hsa-miR-4430、hsa-miR-4306、hsa-miR-22-3P、hsa-miR-486-5P、hsa-miR-371b-5P、hsa-miR-92a-3P 和 hsa-miR-5001-5P。患者中下调最多的前 10 个 miRNAs 是 hsa-miR-3195、hsa-miR-4767、hsa-miR-3135b、hsa-miR-6087、hsa-miR-1181、hsa-miR-4785、hsa-miR-718、hsa-miR-3141、hsa-miR-652-5P 和 hsa-miR-6126。与正常对照组相比,海洛因成瘾患者中 hsa-miR-181a 的表达水平显著升高(P<.001)。hsa-miR-181a 的受试者工作特征曲线下面积为 0.783,灵敏度为 0.867,特异性为 0.551。
海洛因患者血浆中 hsa-miR-181a 的表达增加可能是海洛因滥用病理过程的结果。本研究强调了 hsa-miR-181a 作为海洛因成瘾诊断的新型生物标志物的潜力。